Bufencon Dosage & Drug Information

Concise Prescribing Info

Contents

Per mL Betamethasone dipropionate 5 mg, betamethasone disodium phosphate 2 mg

Indications/Uses

Rheumatic disorders, collagen disease, allergic states.

Dosage/Direction for Use

IM inj 1-2 mL. IA inj 0.25-1 mL, depending on joint size. Intradermal inj Max: 1 mL. Intralesional inj 0.25-1 mL, depending on lesion size.

Contraindications

Not for IV use. Systemic infections; inj into unstable joints, infected areas & intervertebral spaces. Childn <2 yr, neonates.

Special Precautions

Secondary adrenocortical insufficiency on long-term use. Local infections. Pregnancy & lactation.

Adverse Reactions

Fluid & electrolyte, musculoskeletal, GI, dermatologic, neurologic, endocrine, ophth & metabolic disturbances.

View ADR Reporting Link

Drug Interactions

Reduced plasma level of salicylates. Metabolism altered by phenytoin. Increased clearance by phenobarb. Hyperglycaemic effect of betamethasone may offset the hypoglycaemic effect of oral antidiabetic drugs.

MIMS Class

Corticosteroid Hormones

ATC Classification

H02AB01 - betamethasone ; Belongs to the class of glucocorticoids. Used in systemic corticosteroid preparations.

Regulatory Classification

Presentation/Packing

Form

Bufencon inj

Packing/Price

5 mL x 10 × 1's

Bufencon

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries